CBC & Mubadala in Neurology and Allergy Play
27 Aug 2024
US$ 19.00
CBC Group and Mubadala Investment Co have agreed to buy the neurology and allergy business in China from UCB SA ......
Related Publications
Creaegis has led the US$45 million Series B funding round for subscription-based employee healthcare provider Onsurity...
The Longreach Group (Longreach) announced the final closing of Longreach Capital Partners 4 (Longreach 4) at ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.